Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Study finds pancreatic cancer gene in smokers:

This article was originally published in Clinica

Executive Summary

A study has found that heavy smokers who lack both copies of a gene called GSTT1 may run a higher risk of developing pancreatic cancer. Male smokers lacking the gene, which encodes for glutathione S-transferase enzymes, had a 3.2-fold increased relative risk of developing pancreatic cancer compared with non-smokers who have both copies of the gene. Notably, female smokers had a 5-fold increase in risk. The findings, by Dr Eric Duell and colleagues of the Harvard School of Public Health, appear in the Journal of the National Cancer Institute (February 20).





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts